Folabomi A. Oladosu, BS, William Maixner, PhD, DDS, Andrea G

Slides:



Advertisements
Similar presentations
RNA Structure and Transcription Mrs. MacWilliams Academic Biology.
Advertisements

Complexities of Gene Expression Cells have regulated, complex systems –Not all genes are expressed in every cell –Many genes are not expressed all of.
Genes in ActionSection 2 Section 2: Regulating Gene Expression Preview Bellringer Key Ideas Complexities of Gene Regulation Gene Regulation in Prokaryotes.
Celebrating the Sesquicentennial of Mayo Clinic: 150 Years of Advances in Medical Practice, Education, Research, and Professionalism  William L. Lanier,
Untitled (Sailboats) by Leo Sewell
Diverticulosis and Diverticulitis
Flowers in Vase and Table Setting by William Schulman
Jump Start Answer the following in your journal:
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
Ductal Carcinoma in Situ of the Breast
Amyotrophic Lateral Sclerosis: An Update for 2018
Diverticulosis and Diverticulitis
Crohn Disease: Epidemiology, Diagnosis, and Management
RNA.
William L. Lanier, MD  Mayo Clinic Proceedings 
Review of Childhood Obesity
Mythological Botanical No. 1 and No. 2 by Trudy Kraft
Vulvovaginal Issues in Mature Women
What is RNA? Do Now: What is RNA made of?
Understanding Palliative Care and Hospice
Untitled by Martin Blank
From Prescription to Transcription: Genome Sequence as Drug Target
Bronze Statues by Jane DeDecker
Topical Analgesics in the Management of Acute and Chronic Pain
Biology of the immunomodulatory molecule HLA-G in human liver diseases
Acupuncture Mayo Clinic Proceedings
Madonna della Pietá by Michelangelo
Red River and October, Paramecium Pond by Gordon Mortenson
α1-Adrenoceptor Subtype Selectivity and Lower Urinary Tract Symptoms
Pharmacogenomic variability and anaesthesia
Metastatic Breast Cancer
Mayo Clinic Proceedings 2013: Report From a New Vista
Pancreatic Ductal Adenocarcinoma
Gray-Blue Sclerae and Osteopenia Secondary to Osteogenesis Imperfecta
YouFei Guan, M.D., Ph.D., Matthew D. Breyer  Kidney International 
Alternative splicing in heart surgery: Lost in translation?
Arnau Cordomí, Gemma Navarro, María S. Aymerich, Rafael Franco 
Pharmacogenomics: Precision Medicine and Drug Response
Classic Hodgkin Lymphoma
Division of Labor: Minor Splicing in the Cytoplasm
Molecular mechanisms of IgE regulation
Renal Pyelocalyceal Squamous Cell Carcinoma
Evaluation and Management of Penicillin Allergy
Alternative Splicing: New Insights from Global Analyses
From gene to protein.
IGS V, Series #4 by Marvin B. Lipofsky
Institutional Review Boards: What Clinician Researchers Need to Know
Diabetic Mastopathy Mayo Clinic Proceedings
An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:
Microphthalmia-Associated Transcription Factor (MITF): Multiplicity in Structure, Function, and Regulation  Shigeki Shibahara, Kazuhisa Takeda, Ken-ichi.
Leadership Models in Health Care—A Case for Servant Leadership
Allen D. Seftel, MD, Martin Kathrins, MD, Craig Niederberger, MD 
RNA.
Hepatocellular Carcinoma
Down River by Charles Munch
Celebrating the Sesquicentennial of Mayo Clinic: 150 Years of Advances in Medical Practice, Education, Research, and Professionalism  William L. Lanier,
Ross Arena, PhD, PT, FAHA, Carl J. Lavie, MD  Mayo Clinic Proceedings 
Mantle Cell Involvement of the Spleen
Squamous Cell Carcinoma of the Tongue
Pink Manta by Joseph Pagano
Minnesota Birds and Flora by Emily Wilson
The Potential of Medicare Accountable Care Organizations to Transform the American Health Care Marketplace: Rhetoric and Reality  David J. Ballard, MD,
21st Century Women's Health
Volume 7, Issue 1, Pages 1-11 (July 1997)
Conformational Ensembles in GPCR Activation
Diagnosis and Management of Headache in Older Adults
Mayo Clinic Proceedings 2012: “A New Era in Journal Stewardship”
Fiona H. Marshall  Trends in Biochemical Sciences 
Volume 12, Issue 5, Pages (May 2005)
Presentation transcript:

Alternative Splicing of G Protein–Coupled Receptors: Relevance to Pain Management  Folabomi A. Oladosu, BS, William Maixner, PhD, DDS, Andrea G. Nackley, PhD  Mayo Clinic Proceedings  Volume 90, Issue 8, Pages 1135-1151 (August 2015) DOI: 10.1016/j.mayocp.2015.06.010 Copyright © 2015 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 1 G protein–coupled receptor (GPCR) structure and function. A, G protein–coupled receptors are composed of 7-transmembrane domains (gray) interconnected by 3 intracellular (orange) and 3 extracellular (purple) loops. On the end of the first and last transmembranes are the N-terminus (blue) and C-terminus (red), respectively. As its name suggests, a GPCR is bound to a trimeric G protein composed of α and β/γ subunits. B, When a ligand (black circle) binds to a GPCR, the associated G protein separates into the α and β/γ subunits. These subunits then stimulate a variety of downstream effectors that produce changes in cellular activity (see Table 1). Mayo Clinic Proceedings 2015 90, 1135-1151DOI: (10.1016/j.mayocp.2015.06.010) Copyright © 2015 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 2 Different types of alternative splicing. The most common type of alternative splicing in animals is exon skipping (A), in which a constitutive exon is spliced from the final messenger RNA (mRNA) transcript. Alternative 3′ (B) and 5′ (C) splice sites provide additional junctions within an exon, resulting in partial splicing of the exonic mRNA sequence. D, Intron retention is a rare type of alternative splicing that occurs when an intron remains within the final mRNA transcript. Mayo Clinic Proceedings 2015 90, 1135-1151DOI: (10.1016/j.mayocp.2015.06.010) Copyright © 2015 Mayo Foundation for Medical Education and Research Terms and Conditions

Figure 3 Structural variations in G protein–coupled receptors (GPCRs) as a result of alternative splicing. Exons within the messenger RNA transcript serve as coding regions for specific sections of protein. Alternative splicing events that change or remove exonic sequences can produce GPCR splice variants with corresponding changes in protein composition and/or structure. A, Splicing events that lead to alterations in exon 1 can yield GPCRs with truncated N-termini that affect ligand binding, while events that lead to alterations in exon 4 can yield GPCRs with truncated C-termini that affect G protein coupling and signaling. B, Splicing events can also lead to skipping of an exon that codes for a unit of the GPCR, such as a transmembrane, thus yielding a truncated GPCR lacking the encoded section, such as a 6-transmembrane (6-TM) splice variant. Mayo Clinic Proceedings 2015 90, 1135-1151DOI: (10.1016/j.mayocp.2015.06.010) Copyright © 2015 Mayo Foundation for Medical Education and Research Terms and Conditions